URGN 17.26 ▼ -4.06% Live Trading Data - Stocknear

UroGen Pharma Ltd.

NASDAQ: URGN · Real-Time Price · USD
17.26
-0.73 (-4.06%)
At close: Sep 25, 2025, 3:59 PM
17.25
-0.06%
After-hours: Sep 25, 2025, 04:58 PM EDT
-4.06%
Bid 17.03
Market Cap 798.52M
Revenue (ttm) 94.24M
Net Income (ttm) -154.97M
EPS (ttm) -3.06
PE Ratio (ttm) -5.64
Forward PE -22.07
Analyst Buy
Dividends n/a
Ask 17.5
Volume 876,706
Avg. Volume (20D) 1,253,250
Open 17.99
Previous Close 17.99
Day's Range 17.05 - 17.99
52-Week Range 3.42 - 21.71
Beta 1.12
Ex-Dividend Date n/a

About URGN

undefined

Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol URGN
Website n/a
Full Company Profile

Analyst Forecast

According to 0 analyst ratings, the average rating for URGN stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.

Stock Forecasts
UroGen Pharma Ltd. is scheduled to release its earnings on Nov 5, 2025, before market opens.
Analysts project revenue of ... Unlock content with Pro Subscription
3 months ago
+8.57%
UroGen Pharma shares are trading higher after Gugg... Unlock content with Pro Subscription
3 months ago
+51.78%
UroGen Pharma shares are trading higher after the FDA approved ZUSDURI for intravesical solution a the first and only medication for recurrent low-grade intermediate-risk non-muscle invasive bladder cancer.